Update Oncology & Haematology Vol 12 Issue 8 August 2026

Trauma-informed care is a “powerful equity tool” in cervical screening, states Dr Rachael Comer (PhD), Education...

Blinatumomab (BLI), inotuzumab ozogamicin (INO), and CAR T cell therapy have reshaped the treatment of relapsed/refractory...

The current standard treatment for light chain amyloidosis (AL) is chemotherapy. While often effective, it can...

The CD3×CD20 bispecific antibody (bsAb), epcoritamab, is approved as monotherapy for R/R diffuse large Bcell lymphoma...

Breast cancer in younger women, typically defined as diagnosis under the age of 40, accounts for...

Triplet therapy with azacitidine (AZA), venetoclax (VEN), and the FLT3 inhibitor gilteritinib (GILT) induces a high...

In May of this year, the European Hematology Association (EHA) produced its first guideline for the...

PET-guided brentuximab vedotin, etoposide, cyclophosphamide, adrip/doxorubicin, dacarbazine, and dexamethasone (BrECADD) is an effective...

Over the past few decades, treatments for malignancies in children, adolescents, and young adults (CAYA) have...

Anti-CD7 CAR T cell therapy demonstrates rapid and deep MRD-negative remission in a subset of patients...

Nuclear medicine consists of imaging which displays the functional information of various organs and tissues, and...